Subcutaneous sarcoidosis during pegylated interferon alfa and ribavirin treatment for chronic hepatitis C

Dermatology Research and Practice

Volumn 2010, Issue 1, 2010, Pages

  Rodriguez Lojo R ^a   Almagro, M ^a   Barja, J M ^a   Pineyro F ^a   Perez Varela L ^a   Del Pozo, J ^a   Yebra Pimentel, M T ^a   Fonseca, E ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889593629     PISSN: None     EISSN: 16876113     Source Type: Journal    
DOI: 10.1155/2010/230417     Document Type: Article

References (11)

1. Hashimoto Y., Kanto H., Itoh M., Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus. Journal of Dermatology 2007 34 8 577 582 2-s2.0-0033024781 10.1111/j.1346-8138.2007.00336.x (Pubitemid 47228537)
2. Blackard J. T., Kemmer N., Sherman K. E., Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 2006 44 1 15 22 2-s2.0-0036904162 10.1002/hep.21283 (Pubitemid 44049134)
3. Cardinali C., Gerlini G., Caproni M., Pimpinelli N., Fabbri P., Hepatitis C virus: a common triggering factor for both nodular vasculitis and Sjögren's syndrome? British Journal of Dermatology 2000 142 187 189 (Pubitemid 30074502)
4. Hurst E. A., Mauro T., Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature. Archives of Dermatology 2005 141 7 865 868 2-s2.0-0033048585 10.1001/archderm.141.7.865 (Pubitemid 41058068)
5. Guilabert A., Bosch X., Julià M., Iranzo P., Mascaró J. M. Jr., Pegylated interferon alfa-induced sarcoidosis: two sides of the same coin. British Journal of Dermatology 2005 152 2 377 379 2-s2.0-0036207651 10.1111/j.1365-2133.2005.06326.x (Pubitemid 40343622)
6. Cogrel O., Doutre M. S., Marlière V., Beylot-Barry M., Couzigou P., Beylot C., Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection: two cases. British Journal of Dermatology 2002 146 2 320 324 2-s2.0-0033024781 10.1046/j.0007-0963.2001.04570. x (Pubitemid 34264409)
7. Adla M., Downey K. K., Ahmad J., Hepatic sarcoidosis associated with pegylated interferon alfa therapy for chronic hepatitis C: case report and review of literature. Digestive Diseases and Sciences 2008 53 10 2810 2812 2-s2.0-0036215645 10.1007/s10620-008-0209-y
8. Nawras A., Alsolaiman M. M., Mehboob S., Bartholomew C., Maliakkal B., Case report: systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon- α treatment for chronic hepatitis C and review of the literature. Digestive Diseases and Sciences 2002 47 7 1627 1631 2-s2.0-0031861045 10.1023/A:1015843908536 (Pubitemid 34753946)
9. Tahan V., Ozseker F., Guneylioglu D., Sarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature. Digestive Diseases and Sciences 2003 48 1 169 173 2-s2.0-0032055507 10.1023/A:1021759120428 (Pubitemid 36232777)
10. Rogers C. J., Romagosa R., Vincek V., Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C. Journal of the American Academy of Dermatology 2004 50 4 649 650 2-s2.0-13344295070 10.1016/j.jaad.2003.06.013 (Pubitemid 38393185)
11. Wendling J., Descamps V., Grossin M., Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C. Archives of Dermatology 2002 138 4 546 547 2-s2.0-13344295070 (Pubitemid 34290046)